NIH-funded research R01 grant

Making it easier for people to confirm if they are allergic to penicillin

Official title: Improving Equitable Access to Penicillin Allergy De-Labeling

Funded at Massachusetts General Hospital · NIH-11035094 · Data updated 2026-11-12

This study is looking for ways to help people who think they're allergic to penicillin find out if they really are, so they can get better antibiotics and stay healthier, especially in communities that need more support.

More Allergy research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionMassachusetts General Hospital
NIH-funded
Lab location1 site (Boston, United States)
Project startMay 1, 2023
Project endFebruary 29, 2028
Funding year2025
Award (this year)$249,967
NIH project number5R01HS029319-04
Project IDNIH-11035094 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals who have been labeled as allergic to penicillin but have not undergone formal testing to confirm this allergy.

Less likely to help

Patients who have a confirmed penicillin allergy or those who do not have access to healthcare services may not benefit from this research.

What this research studies

This research aims to improve access to penicillin allergy de-labeling, which is the process of confirming whether individuals who believe they are allergic to penicillin actually have a true allergy. Many people mistakenly report a penicillin allergy, leading to the use of less effective antibiotics that can cause more health issues. The project will explore strategies to make this de-labeling process more equitable, particularly for communities that face health disparities. By focusing on proactive measures in outpatient settings, the research seeks to reduce the prevalence of antimicrobial resistance and improve patient outcomes.

Why it matters

Potential benefit: If successful, this research could lead to more accurate penicillin allergy assessments, allowing patients to receive better antibiotic treatments and reducing the risk of antimicrobial resistance.

How similar studies have gone: Previous research has shown that de-labeling efforts can improve antibiotic prescribing practices, indicating potential success for this approach.

Where this research is happening

  • Massachusetts General Hospital
    Boston, United States
    Active

Researchers

  • Principal investigator: Blumenthal, Kimberly Gold — Massachusetts General Hospital
  • Study coordinator: Blumenthal, Kimberly Gold

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.